Comparison of six-month outcomes for primary percutaneous revascularization for acute myocardial infarction with drug-eluting versus bare metal stents (from the APEX-AMI study).

@article{Patel2009ComparisonOS,
  title={Comparison of six-month outcomes for primary percutaneous revascularization for acute myocardial infarction with drug-eluting versus bare metal stents (from the APEX-AMI study).},
  author={Manesh R. Patel and Matthias Emil Pfisterer and Amadeo Betriu and Petr Widmisky and David R. Holmes and William W O'neill and Amanda S Stebbins and Frans J J Van De Werf and Paul Wayne Armstrong and Christopher B. Granger},
  journal={The American journal of cardiology},
  year={2009},
  volume={103 2},
  pages={181-6}
}
We evaluated the use and outcomes of drug-eluting stents (DESs) and bare metal stents (BMSs) in a large primary percutaneous coronary intervention (PCI) acute ST-elevation myocardial infarction (MI) trial. Recently concerns have been raised with "off-label" use of DESs for short- and long-term clinical outcomes. Limited randomized data exist evaluating DESs versus BMSs in ST-elevation MI. Patients (n=5,745) in the Assessment of Pexelizumab in Acute Myocardial Infarction (APEX-AMI) trial were… CONTINUE READING

Citations

Publications citing this paper.
Showing 1-8 of 8 extracted citations

Optimizing primary PCI beyond "door to intervention time"--are we there yet?

Cardiovascular revascularization medicine : including molecular interventions • 2010

Similar Papers

Loading similar papers…